Pricing Log in Create free account

PMGC Holdings Inc. (ELAB) vs Atrinsic Inc. (PTIX)

PMGC Holdings Inc. and Atrinsic Inc. are both Biotechnology companies. PMGC Holdings Inc. and Atrinsic Inc. are of similar size ($1.3M and $1.3M). PMGC Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.2×. Atrinsic Inc. has the higher net margin (0.00% vs −523.0%) and the lower return on invested capital (−229.9% vs 0.00%). Across the 14 metrics below, Atrinsic Inc. leads on 9 and PMGC Holdings Inc. on 5.

Valuation

Metric ELAB PTIX Biotechnology median
P/E n/m 0.24 10.60
P/S 0.31 n/m 9.40
P/B 0.05 0.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.58 n/m 0.66
EV/Sales (6.87) n/m 9.02
Earnings yield (127,538.28%) 412.96% (32.88%)
Free cash flow yield (1,131.30%) (220.47%) (23.13%)

Profitability

Metric ELAB PTIX Biotechnology median
Gross margin 31.08% 0.00% 68.51%
Operating margin (458.63%) 0.00% 0.00%
Net margin (522.99%) 0.00% 0.00%
Free cash flow margin (348.69%) 0.00% 0.00%
Return on equity (104.60%) (338.24%) (51.96%)
Return on assets (58.71%) 378.63% (46.06%)
Return on invested capital 0.00% (229.86%) 0.00%

Growth

Metric ELAB PTIX Biotechnology median
Revenue growth (TTM) 5.41% — 6.76%
EPS growth (last fiscal year) 94.22% 188.24% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ELAB PTIX Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 1.36 0.66 4.97
Net debt to EBITDA 0.87 0.52 1.01

Dividend

Metric ELAB PTIX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELAB PTIX Biotechnology median
Market cap 1.33m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack